Publications by authors named "Diana Vari-Mezo"

Claim this Profile
I
In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy.
Jacopo Gomena, Daniela Modena, Paola Cordella, Balázs Vári, Ivan Ranđelović

Eur J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
Gábor Mező, Jacopo Gomena, Ivan Ranđelović, Endre Levente Dókus, Krisztina Kiss

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Melanocortin 1 Receptor in Melanoma: Biological Activity of α-MSH-Peptide Conjugates.
Ildikó Szabó, Beáta Biri-Kovács, Balázs Vári, Ivan Ranđelović, Diána Vári-Mező

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SREKA-targeted liposomes for highly metastatic breast cancer therapy.
Balázs Vári, Levente Dókus, Adina Borbély, Anikó Gaál, Diána Vári-Mező

Drug Deliv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets.
József Tóvári, Diána Vári-Mező, Sára Eszter Surguta, Andrea Ladányi, Attila Kigyós

Cells· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of fast-dissolving dosage forms of curcuminoids by electrospinning for potential tumor therapy application.
Krisztina Kiss, Kristóf Hegedüs, Panna Vass, Diána Vári-Mező, Attila Farkas

Int J Pharm· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis